Fresenius Medical Care AG & Co. KGaA announced that it has reached a settlement in principle to end an investigation of possible FCPA violations. The company disclosed in its regulatory filing that it has recorded charges of € 224 million encompassing estimates for the government’s claims for profit disgorgement, penalties, and incurred and expected legal expenses, impairments, and costs.
February 20, 2019
German dialysis equipment supplier reaches settlement in principle with US authorities in FCPA probe
Related by Topic
DOJ declines to prosecute Corsa Coal for foreign bribery
March 14, 2023 News Alert
Rio Tinto settles FCPA charges for $15 million
March 13, 2023 News Alert